| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |